Osteoinduction is the formation of ectopic bone that follows implantation of demineralized allogeneic bone matrix (DABM) and is believed to be secondary to the release of associated inductive factors from bone matrix. To clarify the role of vitamin D in osteoinduction, we implanted DABM from vitamin D-deficient rats (-D rats) into normal rats (+D rats). Because mitogens and osteocalcin might be involved in osteoinduction, these were measured. Mitogenic activity in extracts from mineralized allogeneic bone matrix (ABM) and DABM from both +D and -D rats was determined with an assay that utilizes monolayer cultures of embryonic chick calvarial cells. Osteocalcin in serum and DABM was measured by radioimmunoassay. DABM from -D rats did not promote osteoinduction as effectively as DABM from +1 rats. Resorption of implant matrix from -D rats was diminished compared with resorption of matrix from +D rats (P < 0.01), and the decrease was attributed to a corresponding decrease in the number of osteoclasts in the implants (P < 0.02). Bone formation (P < 0,01) and total implant mineralization (P < 0.001) were significantly reduced in implants from -D rats, and the reductions corresponded with a decline in the number of osteoblasts (P < 0.05). Mitogenic activity in DABM from +D rats was only slightly decreased as compared with activity in ABM, but DABM from -D rats contained significantly less activity (P < 0.001). No mitogenic activity was identified in implants of DABM from either +D or -D rats 3 wk after implantation. Serum osteocalcin was significantly higher in -D as compared with +D animals. In contrast, the concentrations of osteocalcin in DABM from the two groups of animals were not significantly different from each other. These findings indicate that the diminished osteoinductive activity of DABM from -D rats results from deficiency of one or more mitogenic factors that are essential for inducing the proliferation and differentiation of bone cells at the implant site and that osteocalcin does not play a role in this regard.
fects of DABM on uncommitted mesenchymal cells causing them to proliferate and differentiate toward an osteoblastic phenotype (1, 2) . This phenomenon, which recapitulates the endochondral bone forstation observed at osseous sites, is believed to result from release of mitogens from DABM. These mitogens were designated bone morphogenetic proteins (3) (4) (5) and bone-derived growth factors (2) .
The role ofcalcium-regulating hormones, vitamin D, parathyroid hormone and calcitonin, and ions such as calcium and phosphate in mediating osteoinduction is not known. There is evidence that vitamin D deficiency results in abnormalities in skeletal growth, remodeling, and mineralization (6) . Consistent with these findings is the observation that osteoinduction is impaired when implants of DABM from normal rats are inserted into vitamin D-deficient rats (-D rats) (7, 8) .
Whereas defects in bone formation and bone resorption occur, the sequence of cellular events is not altered. Bone produced during vitamin D deficiency also was shown to be different biochemically. Rachitic collagen has increased hydroxylation oflysine (9, 10) , altered cross-linking (11, 12) , variable changes in the concentration and incorporation ofglycosaminoglycans (13, 14) , and changes in the content of phospholipid (8) . Bone inductive proteins isolated from matrix produced in rachitic rats also were shown to be diminished (15). In view of these findings, the present studies were conducted to determine if defective osteoinduction seen in vitamin D deficiency is associated with diminished concentration or altered release of bone specific mitogens from bone matrix. Since synthesis of osteocalcin or Gla protein by osteoclasts is enhanced by 1,25-dihydroxyvitamin D3 [1, 25(OH) 2D3] (16, 17) , and since osteocalcin may be chemotactic for bone-forming cells (18) , deficiency of osteocalcin could influence the osteoinductive response. Therefore, the concentration of osteocalcin in serum and in the implants also was determined. Methods Animals. Weanling Sprague-Dawley rats were obtained from Holtzman (Madison, WI). Donor animals which were used to make DABM for implants were fed ad libitum a semisynthetic diet which contained 0.6% calcium and 0.6% phosphorus (19) . Half of the rats received a dietary supplementation of 2 IU of vitamin D3 per gram of diet (+D rats), and the other half were raised in the dark and were fed the same diet but received no vitamin D (-D rats). The animals were maintained on their respective diets for 3 mo. Recipient animals for the implants were raised on the same diet and received the same supplement of vitamin D3.
Preparation of allogeneic bone matrix and DABM. The DABM powder was prepared according to a modification of a protocol previously described (5) . Femoral and tibial diaphyses from +D and -D rats were utilized. At least 16 animals were used for each preparation.
Bones from -D rats were grossly rachitic. There were shortening ofthe shafts, widening of the epiphyses, and increased pliability. The bones were stripped of soft tissue, crushed with a hammer, and rinsed in five changes of distilled water for 1 h. The bone was then extracted with 100% ethanol (three changes in 1 h) and subsequently extracted with chloroform/methanol 1:1 (three changes in 1 h). Bone samples were dried overnight at 30'C. The dried bone was crushed in a mill and sieved to a particle size ranging from 90 to 850 ,m in diameter. This allogeneic bone matrix (ABM) was decalcified at 250C for 4 h with 0.5 N HCI at 25 meq/g dried bone powder. After demineralization, the DABM was rinsed exhaustively in distilled water (10 changes in 2 h), dehydrated in 100% ethanol (three changes in 1 h), extracted in chloroform/methanol 1:1 (three changes in 1 h), and dried overnight at 30'C. The DABM was stored at -70'C. Before implantation, DABM was rinsed in sterile PBS. Nonosteoinductive DABM was prepared by heating DABM from +D rats at 100IC for 2 h. Implantation and analysis. DABM (20 mg) was inserted subcutaneously in thoracic and upper abdominal sites of +D recipient rats.
Preliminary experiments confirmed the importance of the site of implantation so that thoracic and upper abdominal and not lower abdominal sites were used (20) . There were two DABM implants from +D rats, two DABM implants from -D rats, and one nonosteoinductive DABM implant from +D rats in each animal. Ether was used as an anesthetic, and all surgical procedures were performed under aseptic conditions. Rats were killed 2, 3, and 10 wk after implantation. One implant from a +D rat and one implant from a -D rat were fixed in calcium acetate formalin, pH 6.8-7.0, decalcified, dehydrated, and embedded in JB-4 (Polysciences, Inc., Warrington, PA). 4-nm sections were stained with either toluidine blue or hematoxylin and eosin. The remaining implants were radiographed and then used for determination of calcium content and mitogenic activity. These samples were homogenized in 2 ml of distilled water with a polytron probe and centrifuged at 500 g. Precipitates were resuspended in 2 ml of 1 N HC1 and were extracted for 48 h at 4°C. After centrifugation at 500 g, the solubilized extracts were stored at 4°C until further analysis. Calcium content of implants was measured by fluorometric titration assay (Calcette, Precision Systems, Inc., Sudbury, MA).
For analysis of osteocalcin in implants, 5 mg of DABM each from -D and +D rats was extracted by incubation for 18 h at 4°C in a metabolic shaker in I ml 0.5 M EDTA Tris buffer, pH 6.5. After incubation, the mixture was centrifuged at 1,800 g for 10 min at 4°C, and osteocalcin in the supernatant was analyzed by radioimmunoassay (see below).
Quantitative histomorphometric analysis. Randomized histologic samples were used for quantitative histomorphometric analysis of implants from +D Mitogenic activity. Samples of ABM, DABM from -D and +D rats, and implants of DABM recovered 3 wk after implantation were transferred to dialysis tubing (nominal cutoff: 12,000-14,000 mol wt) in 5 ml of 10% EDTA, pH 7.4, and dialyzed against 500 ml ofthe same EDTA solution for 7 d at 4VC with continuous stirring. The soluble extracts were then removed from the dialysis tubing, separated from the organic residues (primarily collagen) by centrifugation, and individually dialyzed against 2 liters of 5 mM phosphate buffer for 14 d with a minimum of six changes of the buffer.
The dialyzed extracts were concentrated by lyophilization and were sterilized by microfiltration (Gelman Sciences, Inc., Ann Arbor, MI) (21) . Protein was determined by the binding method of Bradford (22 There are two major sources of variations in these assays: those between different preparations of calvarial cells and those between different configurations of tissue culture plate.
First, the primary cultures of embryonic chick calvarial cells used in these assays were prepared at weekly intervals, and significant variations in the magnitude of the response to effectors was seen with different cell preparations. This finding may be due to variations in the ratio of progenitor cells to differentiated osteoblasts. For example, the mitogenic response to the addition of 1% fetal calf serum, included as a positive control, varied between 430 and 1,180% of control in the cell preparations used for these investigations. Because this variation in response was large between cell preparations but relatively small within a given cell preparation, that is, the coefficient of variation within cell preparations ranged from 9% to 21%, results are expressed from studies which use the same cell preparation. All observations, however, were confirmed by studies with at least two cell preparations. Second, the absolute value of the mitogenic response of the cells was also different in 48-place multiwell plates as compared to 24-place multiwell plates. During the course of these studies we adapted our assays to 48-place plates so that some of the data were obtained with each system. However, we have made comparisons only in studies from a single preparation of cell and a single 24- 
Results
The -D rats were hypocalcemic and had a serum calcium of < 6.0 mg/dl. Serum 25-OHD was below the detection limit of 0.5 ng/ml, and serum 1,25(OH)2D was below the detection limit of 5 pg/ml, indicating that the animals were severely vitamin D deficient. Implants of DABM from -D rats which had been inserted in +D rats showed reduced calcium content at all time points when compared to implants of DABM from +D rats in the same host animals (Fig. 1) . Qualitative examination of stained sections from implants recovered 2 wk after implantation revealed similar morphologies in DABM from +D rats and -D rats. At this stage the implants were surrounded by a well-organized fibrous capsule. The implant bone matrix particles were largely intact, and there was relatively little new bone matrix. At 3 wk after implantation, the implants from +D rats displayed an extensive network of resorption cavities. These cavities were filled with hematopoietic marrow cells and their surfaces were lined with active osteoblasts and osteoclasts. Gross radiographs of the implants revealed extensive radiodense deposits that were uniformly distributed throughout the implants. In contrast, DABM from -D rats showed no large resorption cavities, little or no hematopoietic cells, and isolated bone surfaces covered with differentiated bone cells. Radiographs of these implants revealed a marked absence of radiodense deposits. By 10 wk after implantation, DABM from +D rats had large central cavities filled with fatty marrow. Although the cavities were bordered by extensive deposits of new bone, the bone surfaces were essentially inactive. By 10 wk after placement, implants from -D rats appeared similar to those obtained at 3 wk for that group except that no differentiated bone cells were observed.
In Table I , quantitative measurements ofthe residual bone matrix area, new bone matrix area, forming surface length, and resorbing surface length in implants from +D rats and -D rats are compared from samples obtained 3 and 10 wk after implantation. At both times, there was significantly more residual bone matrix in implants from -D rats. Furthermore, in the interval from 3 to 10 wk after implantation, the residual bone matrix had decreased significantly in DABM from +D rats, whereas there was no decrease in residual matrix in DABM from -D rats. There were similar amounts of newly formed bone matrix in both types of implants 3 wk after implantation. The newly formed bone in implants of DABM from +D rats had increased significantly during the interval from 3 to 10 wk after implantation. In contrast, no newly formed bone matrix was found in implants from -D rats 10 wk after implantation. Presumably the amount of new bone matrix present at 3 wk was subsequently resorbed. At 3 wk after implantation, the amount of resorbing surface of implants from +D rats was much greater than that of implants from -D rats. No resorbing surface was found in implants from either group 10 wk after implantation. Similarly, 3 wk after insertion the forming surface in implants from +D rats was greater than that of implants from -D rats, and by 10 wk no forming surface was observed in either group.
The values for mitogenic activity in extracts of DABM and ABM from +D and -D rats are summarized in Tables II and  III. In the two studies summarized in Table II Table II were obtained with 24-place plates, and those in Table III were obtained with 48-place plates. Although direct comparison is not possible, separate studies revealed that when cells from a single preparation were used the mitogenic response in an extract of DABM from +D rats averaged 204 U/mg protein in 24-place plates and 516 U/mg protein in 48-place plates. However, the observed ratio of activity in extracts of DABM from +D rats and -D rats was not different regardless ofwhether 24-place or 48-place plates were used.
DABM from -D rats had a significantly lower content of mitogenic activity than DABM from +D animals (Table II) . < 15% additional mitogenic activity was obtained when DABM from +D or -D rats was reextracted (data not shown). This indicates that extraction was equally efficient in both experimental groups. There was significantly less activity in extracts of ABM from -D than from +D rats (Table III) . A reduction of 20% was observed in mitogenic activity in ex- tracts of DABM as compared to extracts of ABM. These findings indicate that the diminished activity in DABM from -D rats does not represent a loss in activity caused by preparation ofthe demineralized matrix but is a property ofbone from -D rats. Further, mitogenic activity was not detected in implants of DABM from +D or -D rats 3 wk after implantation (Table   II) . These results indicate that the mitogenic activity is lost during this interval. The mitogenic activity of DABM was much greater than the activity of bovine serum albumin when the latter was tested at very high concentrations of protein (Fig. 2) .
Serum osteocalcin was significantly higher in the -D than in the +D animals after 12 wk on the respective diets, 98±5 (n = 18) vs. 80±4 (n = 17) ng/ml P < 0.02, respectively. However, the concentration ofosteocalcin in extracts ofthe DABM from -D and +D rats was not different, 15.3±5.6 vs. 12.4±2.9 ng/mg of bone (n = 3), respectively.
Discussion
After implantation of DABM, osteoinduction recapitulates endochondral bone formation in a consistent sequence of cellular events (5, 28, 29 (16) , and increases circulating immunoreactive osteocalcin in normal rats (17) . In contrast to previous findings (31) (32, 33) . The fact that demineralized material was used for the implants in the present study accounts for the low values of osteocalcin. These findings indicate that decreases in osteocalcin did not contribute to defective osteoinduction in implants from -D rats. In this regard, warfarin was shown to deplete osteocalcin in rat bone, and osteoinduction was not altered when implants of warfarin-treated animals were utilized (33) .
Differences in protocol and age of the animal at the time the vitamin D-deficient diet was started may be responsible for the lack of a decrease of osteocalcin in serum and bone of our -D rats. The occurrence of decreases in the concentration of osteocalcin in bone and the circulation reported by other investigators is related to duration ofthe -D diet (30) and may be related to the age at which the diet was begun. It is possible that the values would have declined in our rats had they been started at an earlier age or been kept on the -D diet for a longer period of time.
Osteoinduction requires the invasion and population of implants by host cells. Precursor cells proliferate and differentiate into osteoblasts, osteocytes, and osteoclasts. These processes are regulated, at least in part, by factors released from the implants (2) (3) (4) (5) . It is therefore of considerable interest that the extractable mitogenic activity of DABM from -D rats was dramatically less than that of DABM from +D rats. This defect appears to be in the amount of mitogenic activity rather than altered diffusion ofthe active principle(s) during preparation because the ratio of the mitogenic content of ABM from -D rats compared to ABM from +D rats was similar to the ratio of mitogenic content in DABM from -D rats and in DABM from +D rats. There was a modest decrease in mitogenic activity during preparation of DABM from intact bone. All of the activity in implants of DABM from -D rats as well as activity in implants from +D rats was lost by 3 wk after implantation.
A number of growth factors are produced by rat bone cells (34) including transforming growth factor-,8-like activity (35), (2-microglobulin (36) , and insulinlike growth factor I or somatomedin C (37) . In addition, skeletal growth factor and transforming growth factor-,3-like activity were found in extracts of bovine bone matrix (25) and skeletal growth factor was present in abstracts of human bone (24) . The component(s) responsible for the mitogenic activity in DABM in the present studies has not been identified.
The results of the present studies demonstrate that bone matrix from -D animals is less effective in promoting osteoinduction and contains less mitogenic activity. Whether this mitogenic activity plays a role in osteoinduction remains to be determined.
